Zemaira Kit
Product Images NDC 0053-7201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Zemaira (NDC 0053-7201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Zemaira 01)

Figure 1 (Zemaira 01)
FDA Label Image

Figure 2 (Zemaira 02)

Figure 2 (Zemaira 02)
FDA Label Image

Figure 3 (Zemaira 03)

Figure 3 (Zemaira 03)
FDA Label Image

Figure 4 (Zemaira 04)

Figure 4 (Zemaira 04)
FDA Label Image

Figure 5 (Zemaira 05)

Figure 5 (Zemaira 05)
FDA Label Image

Principal Display Panel (1000 mg Vial Label)

Principal Display Panel (1000 mg Vial Label)
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Zemaira is a medication containing alpha-proteinase inhibitor, for intravenous administration using one single dose vial with diluent. The package includes Steri Vials for injection, USP and a Mix2Vial filter transfer set for reconstitution. Zemaira can be stored up to 25°C (17°F) and should be avoided to be stored in a frozen environment, which may harm the diluent vial. It is manufactured by CSL Behring LLC, Kankakee, IL60301 USA under US License No. 1767.*
FDA Label Image

Zemaira 08

Zemaira 08
This is a description of a medication named "Hygan" or "Zemaira" which is an Alpha-Proteinase Inhibitor and is administered through intravenous injection only. The text also contains other lines that do not seem related to the medication, but rather a set of codes and abbreviations.*
FDA Label Image

Zemaira 09

Zemaira 09
This is a pharmaceutical product description containing information about an intravenous medication called Buniyag 157. The text contains details about the medication, including instructions for storage and dosage. It also includes the NDC (National Drug Code) number and the manufacturer's name (CSLBehring). The text also mentions an Alpha-Proteinase Inhibitor, which is used in the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.